Invasive Candida Infections in the ICU: Diagnosis and Therapy

1. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36:1-53.10.3109/1040841090324144420088682Search in Google Scholar

2. Lepak A, Andes D. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit Care Clin. 2011;27:123-47.10.1016/j.ccc.2010.11.00121144990Search in Google Scholar

3. Ullmann AJ, Cornely OA, Donnelly JP, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect. 2012;Suppl 7:1-77.10.1111/1469-0691.1203723137133Search in Google Scholar

4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63.10.1128/CMR.00029-06179763717223626Search in Google Scholar

5. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54:1739-46.10.1093/cid/cis30522423135Search in Google Scholar

6. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5:161-9.10.4161/viru.26187391637024157707Search in Google Scholar

7. Vincent JL, Rello J, Marshall J, et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323-9.10.1001/jama.2009.175419952319Search in Google Scholar

8. Marchetti O, Bille J, Fluckiger U, et al. Fungal Infection Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38:311-20.10.1086/38063714727199Search in Google Scholar

9. Méan M, Marchetti O, Calandra T. Bench to bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12:204.10.1186/cc6212237459018279532Search in Google Scholar

10. Guery BP, Arendrup MC, Auzinger G, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009;35:55-62.10.1007/s00134-008-1338-718972101Search in Google Scholar

11. Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37:1612-8.10.1097/CCM.0b013e31819efac019325476Search in Google Scholar

12. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur J Clin Microbiol Infect Dis. 2006;25:419-25.10.1007/s10096-006-0159-216773391Search in Google Scholar

13. Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010;16:445-52.10.1097/MCC.0b013e32833e84d220711075Search in Google Scholar

14. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules. 2014;19:1085-119.10.3390/molecules19011085627119624445340Search in Google Scholar

15. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37.10.1186/2110-5820-1-37322446121906271Search in Google Scholar

16. León C, Ostrosky-Zeichner L, Schuster M. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014;40:808-19.10.1007/s00134-014-3281-024718642Search in Google Scholar

17. León C, Alvarez-Lerma F, Ruiz-Santana S, et al. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis. 2009;28:233-42.10.1007/s10096-008-0618-z18758831Search in Google Scholar

18. Magill SS, Swoboda SM, Johnson EA, et al. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis. 2006;55:293-301.10.1016/j.diagmicrobio.2006.03.01316698215Search in Google Scholar

19. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. AnnSurg. 1994;220:751-8.Search in Google Scholar

20. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-21.10.1086/588660267122718462102Search in Google Scholar

21. Scudeller L, Viscoli C, Menichetti F, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263-79.10.1007/s15010-013-0558-024272916Search in Google Scholar

22. Hsu DI, Nguyen M, Nguyen L, Law A, Wong-Beringer A. A multicentre study to evaluate the impact of timing of caspofung in administration on outcomes of invasive candidiasis in nonimmunocompromised adult patients. J Antimicrob Chemother. 2010;65:1765-70.10.1093/jac/dkq21620554567Search in Google Scholar

23. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5.10.1128/AAC.49.9.3640-3645.2005119542816127033Search in Google Scholar

24. Caggiano G, Puntillo F, Coretti C, et al. Candida colonization index in patients admitted to an ICU. Int J Mol Sci. 2011;12:7038-47.10.3390/ijms12107038321102522072934Search in Google Scholar

25. Posteraro B, De Pascale G, Tumbarello M, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index. Crit Care. 2011;15:R249.10.1186/cc10507333480022018278Search in Google Scholar

26. Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med.2014;40:1429-48.10.1007/s00134-014-3355-z417682824934813Search in Google Scholar

27. Eggimann P, Que YA, Revelly JP, Pagani JL. Preventing invasive candida infections. Where could we do better? J Hosp Infect. 2015;89:302-8.Search in Google Scholar

28. León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730-7.10.1097/01.CCM.0000202208.37364.7D16505659Search in Google Scholar

29. León C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37:1624-33.10.1097/CCM.0b013e31819daa1419325481Search in Google Scholar

30. Tissot F, Lamoth F, Hauser PM, et al. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med. 2013;188:1100-9.10.1164/rccm.201211-2069OC23782027Search in Google Scholar

31. Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol. 2005;43:235-43.10.1080/1369378041000173161916010850Search in Google Scholar

32. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007;26:271-6.10.1007/s10096-007-0270-z17333081Search in Google Scholar

33. Ostrosky-Zeichner L, Pappas PG, Shoham S, et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses. 2011;54:46-51.10.1111/j.1439-0507.2009.01756.xSearch in Google Scholar

34. Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev. 1993;6:311-23.10.1128/CMR.6.4.311Search in Google Scholar

35. Morris AJ, Byrne TC, Madden JF, Reller LB. Duration of incubation of fungal cultures. J Clin Microbiol. 1996;34:1583-5.10.1128/jcm.34.6.1583-1585.1996Search in Google Scholar

36. Obayashi T, Yoshida M, Mori T, et al. Plasma (1-->3)-beta-Dglucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17-20.10.1016/S0140-6736(95)91152-9Search in Google Scholar

37. Ellis M, Al-Ramadi B, Finkelman M, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol. 2008;57:287-95.10.1099/jmm.0.47479-018287290Search in Google Scholar

38. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654-9.10.1086/43247016080087Search in Google Scholar

39. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43:5957-62.10.1128/JCM.43.12.5957-5962.2005131718916333082Search in Google Scholar

40. Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, et al. Early treatment of candidemia in adults: a review. Med Mycol. 2011;49:113-20.10.3109/13693786.2010.51230020818922Search in Google Scholar

41. Takesue Y, Kakehashi M, Ohge H, et al. Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg. 2004;28:625-30.10.1007/s00268-004-7302-y15366757Search in Google Scholar

42. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis. 2012;55:521-6.10.1093/cid/cis45622573851Search in Google Scholar

43. Lyons JL, Thakur KT, Lee R, et al. Utility of measuring (1,3)-β-dglucanin cerebrospinal fluid for diagnosis of fungal central nervous system infection. J Clin Microbiol. 2015;53:319-22.10.1128/JCM.02301-14429094625378578Search in Google Scholar

44. Ginocchio F, Verrina E, Furfaro E, Cannavò R, Bandettini R, Castagnola E. Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in child receiving continuous peritoneal dialysis. Clin Vaccine Immunol. 2012;19:626-7.10.1128/CVI.00008-12331826922357650Search in Google Scholar

45. Mutschlechner W, Risslegger B, Willinger B, et al. Bronchoalveolar Lavage Fluid (1,3) β-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study. Transplantation. 2015;99:e140-4.10.1097/TP.000000000000063525710608Search in Google Scholar

46. Schuetz AN. Invasive fungal infections: biomarkers and molecular approaches to diagnosis. Clin Lab Med. 2013;33:505-25.10.1016/j.cll.2013.03.00923931836Search in Google Scholar

47. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14:R222.10.1186/cc9365321998921143834Search in Google Scholar

48. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7:1201-21.10.1586/eri.09.104284539419968513Search in Google Scholar

49. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49:665-70.10.1128/JCM.01602-10304351821106797Search in Google Scholar

50. McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis. 2008;46:890-6.10.1086/52869018260751Search in Google Scholar

51. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm. 2012;69:1910-4.10.2146/ajhp11060423111676Search in Google Scholar

52. Saracli MA, Fothergill AW, Sutton DA, Wiederhold NP. Detection of triazole resistance among Candida species by matrix-assistedlaser desorption/ionization-time of flight massspectrometry (MALDI-TOF MS). Med Mycol. 2015;53:736-42.10.1093/mmy/myv04626162474Search in Google Scholar

53. Skrobik Y, Laverdiere M. Why Candida sepsis should matter to ICU physicians. Crit Care Clin. 2013;29:853-64.10.1016/j.ccc.2013.06.007Search in Google Scholar

54. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5. 10.1128/AAC.49.9.3640-3645.2005Search in Google Scholar

55. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis. 2006;43:25-31.10.1086/504810Search in Google Scholar

56. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113:480-5.10.1016/S0002-9343(02)01248-2Search in Google Scholar

57. Senn L, Eggimann P, Ksontini R, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009;35:903-8.10.1007/s00134-009-1405-819172247Search in Google Scholar

58. Bassetti M, Marchetti M, Chakrabarti A, et al. A research agenda on the management of intra-abdominalcandidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39:2092-106.10.1007/s00134-013-3109-324105327Search in Google Scholar

59. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40:1241-55. Search in Google Scholar